Search research articles
Contact Us
Filters
Showing results (51-60 of 122) with videos related to
Page
of 13
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
June 28, 2017
Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors
Christopher M Yates, Edward P Garvey, Sammy R Shaver, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|
February 4, 2010
Ovarian inflammatory myofibroblastic tumour fistulating on to the anterior abdominal wall
G Khan, A Treacy, J P Garvey, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
September 30, 2008
Increase in VTEC cases in the south of Ireland: link to private wells?
M B O'Sullivan, P Garvey, M O'Riordan, et al.
The Journal of Antimicrobial Chemotherapy
|
June 28, 2018
The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis
E P Garvey, A D Sharp, P A Warn, et al.
Medical Mycology
|
April 3, 2024
Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598
Kenan Gu, Robert Spitz, Erin Hammett, et al.
Nephrology (Carlton, Vic.)
|
November 12, 2010
A successful pregnancy in a dialysis patient with renal cortical necrosis
Catherine M Brown, Claire O'Kane, Betty McDonnell, et al.
Journal of Medicinal Chemistry
|
June 6, 1997
Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity
B G Shearer, S Lee, J A Oplinger, et al.
Antimicrobial Agents and Chemotherapy
|
January 22, 2015
VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model
E P Garvey, W J Hoekstra, W R Moore, et al.
Antimicrobial Agents and Chemotherapy
|
December 14, 2016
Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong <i>In Vitro</i> Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds
W A Schell, A M Jones, E P Garvey, et al.
Clinical Nephrology
|
October 30, 2009
Trimethoprim-sulfamethoxazole induced acute interstitial nephritis in renal allografts; clinical course and outcome
J P Garvey, C M Brown, S H Chotirmall, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 122) with videos related to
Sort By:
Page
of 13
Bioorganic & Medicinal Chemistry Letters
|
June 28, 2017
Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors
Christopher M Yates, Edward P Garvey, Sammy R Shaver, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|
February 4, 2010
Ovarian inflammatory myofibroblastic tumour fistulating on to the anterior abdominal wall
G Khan, A Treacy, J P Garvey, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
September 30, 2008
Increase in VTEC cases in the south of Ireland: link to private wells?
M B O'Sullivan, P Garvey, M O'Riordan, et al.
The Journal of Antimicrobial Chemotherapy
|
June 28, 2018
The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis
E P Garvey, A D Sharp, P A Warn, et al.
Medical Mycology
|
April 3, 2024
Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598
Kenan Gu, Robert Spitz, Erin Hammett, et al.
Nephrology (Carlton, Vic.)
|
November 12, 2010
A successful pregnancy in a dialysis patient with renal cortical necrosis
Catherine M Brown, Claire O'Kane, Betty McDonnell, et al.
Journal of Medicinal Chemistry
|
June 6, 1997
Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity
B G Shearer, S Lee, J A Oplinger, et al.
Antimicrobial Agents and Chemotherapy
|
January 22, 2015
VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model
E P Garvey, W J Hoekstra, W R Moore, et al.
Antimicrobial Agents and Chemotherapy
|
December 14, 2016
Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong <i>In Vitro</i> Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds
W A Schell, A M Jones, E P Garvey, et al.
Clinical Nephrology
|
October 30, 2009
Trimethoprim-sulfamethoxazole induced acute interstitial nephritis in renal allografts; clinical course and outcome
J P Garvey, C M Brown, S H Chotirmall, et al.
Page
of 13